- Home
- ADVM vs OPHC Comparison
ADVM vs OPHC Comparison
Compare ADVM & OPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- OPHC
- Stock Information
- Founded
- ADVM 2006
- OPHC 2000
- Country
- ADVM United States
- OPHC United States
- Employees
- ADVM N/A
- OPHC N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- OPHC Major Banks
- Sector
- ADVM Health Care
- OPHC Finance
- Exchange
- ADVM Nasdaq
- OPHC Nasdaq
- Market Cap
- ADVM 47.4M
- OPHC 51.8M
- IPO Year
- ADVM 2014
- OPHC N/A
- Fundamental
- Price
- ADVM $2.39
- OPHC $4.57
- Analyst Decision
- ADVM Strong Buy
- OPHC
- Analyst Count
- ADVM 5
- OPHC 0
- Target Price
- ADVM $23.80
- OPHC N/A
- AVG Volume (30 Days)
- ADVM 338.5K
- OPHC 7.7K
- Earning Date
- ADVM 08-11-2025
- OPHC 08-05-2025
- Dividend Yield
- ADVM N/A
- OPHC N/A
- EPS Growth
- ADVM N/A
- OPHC 30.24
- EPS
- ADVM N/A
- OPHC 1.33
- Revenue
- ADVM $1,000,000.00
- OPHC $39,980,000.00
- Revenue This Year
- ADVM N/A
- OPHC N/A
- Revenue Next Year
- ADVM $18.82
- OPHC N/A
- P/E Ratio
- ADVM N/A
- OPHC $3.40
- Revenue Growth
- ADVM N/A
- OPHC 53.28
- 52 Week Low
- ADVM $1.78
- OPHC $3.53
- 52 Week High
- ADVM $10.14
- OPHC $5.90
- Technical
- Relative Strength Index (RSI)
- ADVM 44.19
- OPHC 57.75
- Support Level
- ADVM $2.11
- OPHC $4.42
- Resistance Level
- ADVM $2.60
- OPHC $4.62
- Average True Range (ATR)
- ADVM 0.22
- OPHC 0.07
- MACD
- ADVM -0.00
- OPHC 0.01
- Stochastic Oscillator
- ADVM 33.33
- OPHC 65.38
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
About OPHC OptimumBank Holdings Inc.
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.